The present application describes oxygen and sulfur containing heteroaromatics
and derivatives thereof of formula I:
##STR1##
or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is O or
S and D may be C(NH)NH2, which are useful as inhibitors of factor Xa.